| 1 |
Zilovertamab Vedotin (Zv) Alone Or In Combination With Nemtabrutinib In Relapsed Or Refractory (R/R) Aggressive And Indolent B Cell Malignancies (Wave Line 006): An Open Label, Phase 2 Basket Study
|
WoS: WOS:001315579604171
|
Clinical Lymphoma Myeloma & Leukemia
|
WOS
|
Meeting Abstract
|
-
PASKIEWICZ-KOZIK, EWA
-
GLIMELIUS, INGRID
-
MOREIRA, CLAUDIA
-
GARRIDO, MARCELO
-
ERNST, DANIEL
-
JURCZAK, WOJCIECH
-
MERRYMAN, REID
-
KIM, WON S.
-
ÖZCAN, MUHIT
-
SANTORO, ARMANDO
-
SAWALHA, YAZEED
-
BERKOVITS-CACERES, ALEJANDRO
-
REN, YIXIN
-
OGBU, UZOR
-
YUSUF, RUSHDIA
-
ZINZANI, PIER LUIGI
-
13 Autores más
-
Esconder
|
2024
|
| 2 |
Wave Line 006: A Phase 2 Study Of The Safety And Efficacy Of Zilovertamab Vedotin As Monotherapy Or In Combination In Patients (Pts) With Aggressive And Indolent B Cell Malignancies.
|
WoS: WOS:001053772005460
|
Journal Of Clinical Oncology
|
WOS
|
Meeting Abstract
|
-
ZINZANI, PIER LUIGI
-
MAYER, JIRI
-
BENJAMINI, OHAD
-
BERKOVITS-CACERES, ALEJANDRO
-
GLIMELIUS, INGRID
-
STEVENS, DON A.
-
CHAUDHRY, ARVIND
-
DEMIR, AHMET MUZAFFER
-
GARCIA SANZ, RAMON
-
KIM, WON SEOG
-
LI, FEI
-
HALKA, JANUSZ
-
MARIN-NIEBLA, ANA
-
ÖZCAN, MUHIT
-
PASZKIEWICZ-KOZIK, EWA
-
SANTORO, ARMANDO
-
REN, YIXIN
-
OGBU, UZOR
-
MARINELLO, PATRICIA
-
JURCZAK, WOJCIECH
-
17 Autores más
-
Esconder
|
2023
|
| 3 |
Zilovertamab Vedotin Alone Or In Combination With Nemtabrutinib In Aggressive And Indolent B Cell Malignancies: Phase 2wave Line 006 Study
|
WoS: WOS:001098086400082
|
American Journal Of Hematology
|
WOS
|
Meeting Abstract
|
-
ZINZANI, PIER LUIGI
-
MAYER, JIRI
-
BENJAMINI, OHAD
-
BERKOVITS-CACERES, ALEJANDRO
-
GLIMELIUS, INGRID
-
STEVENS, DON
-
CHAUDHRY, ARVIND
-
DEMIR, AHMET MUZAFFER
-
GARCIA SANZ, RAMON
-
KIM, WON S.
-
HALKA, JANUSZ
-
MARIN-NIEBLA, ANA
-
ÖZCAN, MUHIT
-
PASZKIEWICZ-KOZIK, EWA
-
SANTORO, ARMANDO
-
OGBU, UZOR
-
MARINELLO, PATRICIA
-
JURCZAK, WOJCIEICH
-
17 Autores más
-
Esconder
|
2023
|
